Molecular Advances in Pathology, Diagnosis and Treatment of Gynaecological Cancers

Dear Colleagues, 

In recent years, new insights, novel developments, latest discoveries, and future challenges radically changed the field of gynecologic oncology. According to the tumor origin, gynecologic malignancies are mainly classified into ovarian cancer (epithelial, germ cell tumor, sexual-stromal tumor, and others), endometrial cancer, cervical cancer, and vulvar cancer, which are recognized as global health threats for women.

In the past decades, multimodal strategies consisting of surgery, radiation, and chemotherapy were the main choices for these patients with gynecologic malignancies. This research topic aims to provide updates on the newly identified molecular targets and developed therapeutic strategies for gynecological cancers, and to discuss the recent advances on the screening, diagnosis, therapies, and prognosis of gynecological cancers. We welcome submissions of articles which provide novel information in the fields encompassing, but not limited to, the identifications of cancer signaling pathways, potential therapeutic target discoveries, the development of new targeted drugs, and therapeutic strategies for gynecological cancers. The submitted articles in this research topic will help to highlight the current knowledge and trends regarding the targeted therapy of gynecological cancers.

Dr. Valentina Tuninetti
Dr. Alberto Farolfi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.